Physician profile
Katie Chiles
NPI 1801515812
$1,120.72
in general payments reported to CMS, 2019-2025
24 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $284 · 2024: $642 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115 · Education: $5.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.16 |
| Education | $5.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $207.36 | 2023-2025 | |
| Axonics, INC. | $143.30 | 2023-2024 | Axonics, Bulkamid |
| Novo Nordisk INC | $110.27 | 2023-2025 | Rybelsus, Ozempic |
| Endo USA, INC. | $82.43 | 2024-2025 | Aveed, Xiaflex, Edex |
| Sumitomo Pharma America, INC. | $53.82 | 2023-2024 | Gemtesa |
| Beta Bionics, INC. | $51.74 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Convatec INC. | $51.11 | 2023-2024 | |
| Recordati_rare_diseases_inc. | $45.22 | 2024 | Signifor Lar, Isturisa |
| Ferring Pharmaceuticals INC. | $44.40 | 2024 | |
| Procept Biorobotics Corporation | $40.45 | 2024 | Aquabeam System |
| Amgen INC. | $36.03 | 2023-2024 | Evenity, Otezla, Repatha |
| Pfizer INC. | $33.06 | 2023 | |
| Insulet Corporation | $31.93 | 2024 | Omnipod |
| Corcept Therapeutics | $23.31 | 2024 | Korlym |
| Endo Pharmaceuticals INC. | $23.12 | 2023 | Xiaflex, Edex, Aveed |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $20.32 | 2025 | Yorvipath |
| Olympus America INC. | $19.98 | 2025 | Itind System |
| Becton, Dickinson and Company | $18.88 | 2025 | Bard Urinary Drainage Bag |
| Coloplast Corp | $16.26 | 2023 | Saffron |
| Xeris Pharmaceuticals, INC. | $16.14 | 2025 | Gvoke Hypopen |
| Abc Home Medical Supply, INC. | $15.77 | 2024 | |
| Merck Sharp & Dohme LLC | $15.36 | 2023 | Lynparza, Keytruda |
| Dentsply Ih Ab | $14.90 | 2025 | Lofric |
| Travere Therapeutics, INC. | $5.56 | 2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Chiles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.